8 Results for "

CYP450 2D6

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "CYP450 2D6" in MCE Product Catalog:

Cat. No.: HY-N6023
CAS No.: 19993-32-9
Thermopsoside is a CYP450 isoenzyme inhibitor and PXR activator. Thermopsoside inhibits CYP3A4, CYP2C19, CYP2D6 and CYP2C9 with IC50 values of 6.0 μM, 9.5 μM, 12.0 μM and 32.0 μM, respectively .
loading...
    loading...
Cat. No.: HY-115493
CAS No.: 1380336-17-3
Target:  

CXCR

Research Areas:  

Others

TIQ-15 is a potent CXCR4 antagonist with an IC50 value of 6 nM for CXCR4 Ca 2+ flux. TIQ-15 inhibits CYP450 2D6 with an IC50 value of 0.32 μM .
loading...
    loading...
Cat. No.: HY-178479
CAS No.: 2581050-29-3
IDO1-IN-30 (Compound (R)-100) is a potent and highly selective IDO1 inhibitor. IDO1-IN-30 has an IC50 of 4.8 nM to IDO1 in SKOV3 cells. IDO1-IN-30 does not show significant cytotoxicity at 25 µM in HepG2 cells. IDO1-IN-30 can eliminate inhibition of CYP450 enzymes (such as 3A4, 2C9, 2D6). IDO1-IN-30 can be used for research on cancer and inflammatory conditions .
loading...
    loading...
Cat. No.: HY-W803860
CAS No.: 86383-21-3
Research Areas:  

Cardiovascular Disease

N-Depropylpropafenone is an active metabolite of Propafenone (HY-B0432), generated through the CYP450 enzyme system (mainly CYP2D6). It functions by blocking sodium ion channels, slowing myocardial conduction and exhibiting certain antiarrhythmic effects .
loading...
    loading...
Cat. No.: HY-178479A
Target:  

Drug Isomer

Research Areas:  

Others

(Rac)-IDO1-IN-30 is the Rac isomer of IDO1-IN-30 (HY-178479). IDO1-IN-30 is a potent and highly selective IDO1 inhibitor. IDO1-IN-30 has an IC50 of 4.8 nM to IDO1 in SKOV3 cells. IDO1-IN-30 does not show significant cytotoxicity at 25 µM in HepG2 cells. IDO1-IN-30 can eliminate inhibition of CYP450 enzymes (such as 3A4, 2C9, 2D6). IDO1-IN-30 can be used for research on cancer and inflammatory conditions .
loading...
    loading...
Cat. No.: HY-117593
CAS No.: 1369591-04-7
Research Areas:  

Cancer

NSC 23925B is a P-glycoprotein (P-gp) inhibitor, as well as the most biologically active isomer of NSC23925 (HY-19626), which reverses and prevents P-glycoprotein-mediated multidrug resistance in cancer cells. NSC 23925B shows weak inhibition against most CYP450 enzymes (IC50 > 10 μM), and exhibits moderate inhibitory activity against CYP2B6 and CYP2D6 with IC50 values of 8.589 μM and 1.407 μM, respectively. NSC 23925B can be used for the research of multidrug-resistant cancers .
loading...
    loading...
Cat. No.: HY-182908
CAS No.: 2892569-27-4
Target:  

CXCR

Research Areas:  

Others

CXCR4-antagonist-12 is a CXCR4 antagonist with an IC50 of 78 nM. CXCR4-antagonist-12 is applicable to research on cancers with high CXCR4 expression .
loading...
    loading...
Cat. No.: HY-182909
CAS No.: 2892568-27-1
Target:  

CXCR

Research Areas:  

Others

CXCR4-antagonist-11 is a CXCR4 antagonist with CXCR4 IC50 values of 68.9 nM and 48.3 nM. CXCR4-antagonist-11 modulates CXCR4 receptor function. CXCR4-antagonist-11 demonstrates high permeability, selectivity against CYP 2D6, and a high hERG index. CXCR4-antagonist-11 shows improved oral exposure in mouse pharmacokinetic studies .
loading...
    loading...